viru
group
wherea
ebov
contain
four
subtyp
sudan
zair
reston
ivori
coast
natur
reservoir
virus
remain
unknown
although
arthropod
appear
reservoir
hallmark
filovir
vhf
dissemin
intravascular
coagulopathi
dic
death
usual
occur
day
recent
studi
observ
lymphoid
macrophag
peripher
monocyt
infect
ebov
exhibit
increas
secret
tissu
factor
could
trigger
extrins
coagul
pathway
caus
dic
model
corrobor
studi
dic
context
eg
sepsi
dic
also
correl
decreas
protein
c
improv
administr
recombin
protein
c
regard
vaccin
recent
effort
includ
recombin
vaccina
viru
recombin
filovir
protein
nake
dna
recent
report
use
adenovir
vector
encod
ebov
glycoprotein
led
rapid
cellmedi
respons
ebov
challeng
cynomolgu
macaqu
monkey
regard
antivir
treatment
initi
report
use
sadenosylhomocystein
hydrolas
inhibitor
demonstr
protect
effect
mous
model
ebov
infect
recombin
factor
viitissu
factor
inhibitor
success
use
treat
ebov
vhf
rhesu
macaqu
monkey
date
clinic
proven
antivir
drug
human
filovir
vhf
remain
elus
support
care
remain
mainstay
treatment
diagnosi
filovir
vhf
includ
approach
isol
viru
cell
cultur
enzym
immunoassay
eia
elisa
reversetranscriptas
polymeras
chain
reaction
rtpcr
work
must
done
biosafeti
condit
filovirus
seem
demonstr
season
outbreak
tend
occur
earli
wet
season
filovirus
share
categori
classif
mean
high
risk
use
smallpox
anthrax
plagu
specul
exist
filovirus
alreadi
adapt
use
weapon
mass
destruct
caus
agent
prototyp
hemorrhag
fever
renal
syndrom
hfr
korean
hemorrhag
feverwa
first
describ
saw
discoveri
sin
nombr
viru
snv
hantaviru
pulmonari
syndrom
hp
write
multipl
hantavirus
describ
class
hantavirus
caus
hfr
hp
manifest
diseas
like
bunyavirus
hantaviru
genom
consist
three
segment
singlestrand
negativesens
rna
hous
helic
nucleocapsid
segment
genom
rais
question
genet
variat
hantavirus
genet
drift
clearli
play
role
role
genet
shift
less
clear
studi
demonstr
diploid
strain
unstabl
reassort
viru
report
genet
variant
snv
dobrava
viru
notabl
homolog
recombinationth
first
instanc
recombin
negativesens
rna
viruseswa
first
describ
tula
viru
later
dobrava
viru
nonetheless
human
infect
appear
due
encroach
upon
hantaviru
host
habitat
vice
versa
fundament
chang
virus
hantavirus
carri
singl
rodent
speci
geograph
distribut
specif
hantavirusesh
clinic
diseas
causei
tie
host
natur
habitat
hantavirus
nativ
eastern
hemispher
old
world
associ
hfr
hantavirus
nativ
america
associ
hp
hfr
hp
therefor
discuss
separ
case
infect
occur
mean
inhal
dri
rodent
excreta
although
laboratoryborn
utero
infect
also
report
humantohuman
transmiss
hantavirus
occur
notabl
except
hp
caus
and
viru
hfr
classic
defin
four
phase
begin
febril
phase
prodrom
influenzalik
symptom
last
day
incub
period
sudden
extrem
albuminuria
occur
fourth
day
prodrom
hypotens
phase
follow
mark
dic
last
hour
day
reflect
extens
vascular
leak
syndrom
oligur
phase
follow
death
usual
due
renal
failur
phase
last
day
week
patient
recov
progress
diuret
phase
convalesc
last
month
sever
hfr
depend
specif
caus
hantaviru
manag
hfr
involv
treat
shock
pressor
fluid
well
albumin
dialysi
reduc
mortal
volum
manag
highli
import
intraven
ribavirin
administ
within
first
day
ill
demonstr
benefit
hp
also
appear
follow
phase
incub
period
similar
febril
phase
day
durat
occur
thrombocytopenia
may
present
stigmata
coagulopathi
usual
absent
cardiopulmonari
involv
follow
febril
phase
patient
hospit
phase
triad
thrombocytopenia
immatur
granulocyt
circul
lymphoblast
seen
peripher
blood
smear
renal
dysfunct
myositi
also
occur
case
patient
surviv
typic
recov
pulmonari
edema
shock
day
follow
diuresi
excess
fluid
hp
prove
remark
lethal
hp
snv
infect
carri
mortal
rate
differenti
diagnosi
hp
also
includ
bacteri
caus
patient
receiv
antibiot
therapi
consist
therapi
communityacquir
pneumonia
sepsi
includ
yersinia
pesti
aggress
respiratori
support
indic
pack
red
blood
cell
maintain
oxygencarri
capac
appropri
contrast
hfr
therapi
hp
ribavirin
demonstr
much
benefit
inhal
viral
entri
cell
least
hantavirus
appear
mediat
integrin
integrin
found
endotheli
cell
platelet
vigor
immun
respons
note
includ
tlymphocyt
numer
cytokin
immun
respons
thought
caus
vascular
leak
note
hfr
hp
similar
reaction
seen
cancer
patient
receiv
highdos
laboratori
diagnosi
hantaviru
infect
usual
rest
upon
igmdetect
enzymelink
immunosorb
assay
rtpcr
rtpcr
distinguish
among
old
world
hantavirus
tissu
serum
specimen
handl
level
viru
isol
difficult
typic
done
clinic
microbiolog
laboratori
addit
hantaviru
maintain
cell
cultur
accumul
mutat
present
wild
type
state
outbreak
highli
lethal
respiratori
syndrom
among
hors
australia
led
discoveri
novel
paramyxoviru
later
name
hendra
viru
hev
similar
outbreak
pig
caus
outbreak
human
enceph
malaysia
casefat
rate
approach
caus
agent
identifi
distinct
hendralik
viru
later
name
nipah
viru
niv
molecular
studi
demonstr
two
virus
defin
new
genu
paramyxoviru
henipaviru
two
report
human
case
hev
one
patient
die
acut
respiratori
diseas
patient
die
leptomening
year
initi
bout
acut
asept
mening
otherwis
hev
primarili
pathogen
hors
hors
diseas
manifest
fever
respiratori
distress
copiou
frothi
case
bloodting
nasal
discharg
initi
emerg
niv
led
death
human
eventu
cull
million
pig
human
niv
infect
led
encephalit
syndrom
mark
fever
headach
drowsi
disorient
could
rapidli
within
hour
progress
coma
death
viru
appear
contract
contact
infect
pig
followup
studi
suggest
niv
lead
remittingrelaps
pattern
neurolog
diseas
well
pig
niv
caus
acut
respiratori
ill
fever
sometim
nervou
sign
recent
outbreak
nipah
viru
bangladesh
also
appear
encephalit
epidemiolog
distinct
contact
pig
major
factor
epidemiolog
distinct
rais
specul
third
henipaviru
fruit
batsalso
call
fli
fox
appear
natur
reservoir
virus
endem
region
span
eastern
australian
coast
pakistan
humantohuman
spread
demonstr
either
hev
niv
although
patholog
confirm
viru
probabl
spread
among
pig
via
respiratori
rout
diagnosi
henipaviru
infect
involv
viral
cultur
use
vero
cell
rtpcr
immunohistochemistri
indirect
captur
enzymelink
immunosorb
assay
igg
igm
cytopath
effect
cpe
show
syncytia
detach
substrat
leav
punctuat
hole
cell
monolay
immunohistochemistri
safe
perform
wide
varieti
formalinfix
tissu
primari
patholog
occur
vascular
endothelium
ideal
work
done
condit
irradi
heat
inactiv
deterg
treatment
use
make
laboratori
workup
safer
viral
viabil
concern
lethal
concern
exist
possibl
use
niv
biolog
weapon
inde
center
diseas
control
prevent
cdc
list
categori
c
agent
howev
ribavirin
use
openlabel
initi
niv
outbreak
seem
demonstr
benefit
experiment
vaccin
hamster
appear
promis
subfamili
pneumovirina
consist
two
genera
pneumoviru
typifi
human
respiratori
syncyti
viru
hrsv
metapneumoviru
sole
member
metapneumoviru
genu
avian
pneumoviru
apv
year
van
den
hoogen
et
al
cultur
paramyxoviruslik
viru
exhibit
cytopath
effect
indistinguish
hrsv
character
demonstr
new
viru
close
relat
apv
hrsv
viru
therefor
name
human
metapneumoviru
hmpv
retrospect
serolog
studi
suggest
hmpv
circul
among
human
almost
year
sinc
initi
discoveri
hmpv
report
global
hmpv
caus
diseas
isol
virus
commonli
hrsv
whether
coinfect
caus
sever
diseas
unclear
hmpv
caus
lowertract
respiratori
diseas
human
age
flulik
syndrom
malais
myalgia
fever
also
report
associ
hmpv
like
hrsv
diseas
appear
sever
young
children
preliminari
evid
suggest
winter
season
pattern
similar
hrsv
recent
report
indic
hmpv
lead
caus
respiratori
ill
children
genet
studi
suggest
four
subgroup
hmpv
term
laboratori
diagnosi
investig
use
varieti
respiratori
specimensnos
throat
nasopharyng
swab
wash
bronchoalveolar
lavag
fluidbut
mostli
reli
rtpcr
purpos
identif
first
direct
transmiss
avian
influenza
viru
human
observ
strain
influenza
virus
continu
emerg
includ
mutant
attenu
immunogen
diminish
virul
inde
reemerg
southeast
asia
earli
similar
situat
occur
netherland
strain
caus
outbreak
viral
conjunct
one
human
fatal
viru
mutat
present
viru
case
infect
seem
correl
mutat
virus
anoth
concern
increas
preval
strain
domest
poultri
worldwid
strain
infect
human
cocircul
strain
pig
inde
strain
appear
similar
even
radiograph
crystallographi
strain
influenza
pandem
gain
particular
notorieti
recent
studi
demonstr
feasibl
develop
effect
vaccin
possibl
reemerg
monkeypox
viru
mpv
first
isol
first
human
mpv
infect
document
endem
rainforest
region
africa
mpv
never
seen
outsid
africa
last
year
western
hemispher
first
case
report
girl
wisconsin
end
outbreak
case
identifi
six
state
fatal
case
secondari
transmiss
origin
sourc
mpv
appear
least
one
speci
african
rodent
prairi
dog
contact
cdc
us
food
drug
administr
ban
import
african
rodent
although
concern
exist
mpv
may
alreadi
establish
rodent
popul
unit
state
human
mpv
infect
manifest
incub
period
prodrom
fever
malais
last
day
develop
lymphadenopathi
occur
rash
rash
spread
centrifug
pattern
becom
gener
lesion
resolv
period
day
extracutan
manifest
includ
secondari
skinsoft
tissu
infect
pneumon
ocular
complic
enceph
report
casefat
rate
rang
zero
unit
state
africa
clinic
diagnosi
mpv
infect
difficult
partial
rash
mpv
infect
resembl
rash
seen
smallpox
chickenpox
even
herp
simplex
viru
lymphadenopathi
mpv
infect
appear
specif
mpv
histori
contact
exot
anim
also
help
make
diagnosi
laboratori
diagnosi
mpv
also
difficult
sequenc
analysi
distinguish
among
orthopoxvirus
techniqu
take
time
reliabl
rapid
test
still
need
recent
report
use
realtim
pcr
oligonucleotid
microarray
techniqu
appear
promis
current
laboratori
diagnosi
depend
cell
cultur
chick
chorioallanto
membran
isol
conjunct
dnabas
assay
cutan
tissu
eg
vesicular
materi
blood
use
diagnost
purpos
reader
refer
cdc
detail
inform
specimen
collect
transport
mpv
safe
handl
condit
variola
viru
suspect
referr
specimen
state
public
health
laboratori
analysi
cdc
prudent
preand
postexposur
vaccin
vaccinia
viru
prevent
mpv
infect
data
avail
regard
efficaci
antivir
treatment
mpv
although
cidofovir
vaccinia
immun
globulin
use
patient
sever
mpv
infect
patient
mpv
immunodefici
concern
exist
potenti
use
mpv
weapon
bioterror
human
casefat
rate
tend
low
debat
question
effici
aerosol
transmiss
lead
secondari
case
whether
transmiss
would
lethal
evid
indic
mpv
caus
human
infect
remain
stabl
last
decad
mpv
variola
viru
evolv
independentlysuggest
wildtyp
mpv
unlik
evolv
variolalik
viru
nonetheless
expert
cite
result
jackson
et
al
ectromelia
evid
mpv
could
genet
modifi
highli
lethal
biolog
weapon
tanapox
viru
tpv
infect
human
histor
rare
recent
case
report
howev
tpv
harbor
nonhuman
primat
transmit
human
mostli
arthropod
human
tpv
diseas
typic
mild
onset
mild
fever
c
c
headach
myalgia
one
papul
develop
form
nodul
region
lymphadenopathi
resolv
week
onset
clinic
diseas
present
differ
markedli
smallpox
whose
onset
includ
high
fever
multipl
lesion
vaccin
treatment
current
exist
tpv
infect
histor
diseas
selflimit
tpv
member
yatapoxviru
genu
along
yaba
monkey
tumor
viru
ymtv
yabalik
diseas
viru
yldv
member
close
relat
recent
studi
demonstr
tpv
ident
yldv
nucleotid
level
also
human
yldv
infect
clinic
ident
tpv
infect
latter
observ
led
investig
conclud
tpv
yldv
strain
viru
smallpox
extens
describ
literatur
recent
studi
focus
antivir
treatment
vaccin
rapid
test
variola
viru
vv
studi
show
promis
regard
use
cidofovir
investig
drug
treat
smallpox
human
clinic
data
lack
effort
prepar
possibl
use
vv
weapon
therefor
focus
vaccin
complic
vaccin
give
observ
paus
partial
solut
research
new
vaccin
vv
continu
alleg
persist
unauthor
stock
vv
exist
biolog
weapon
research
vv
continu
today
develop
rapid
test
vv
current
effort
gravit
toward
realtim
pcr
dna
microarray
techniqu
novemb
case
new
pulmonari
diseas
later
name
sever
acut
respiratori
syndrom
sar
note
guandong
provinc
china
caus
agent
identifi
april
novel
coronaviru
sarscov
end
first
outbreak
sarscov
juli
sar
afflict
peopl
worldwid
fatal
human
coronavirus
cycl
period
reappear
sar
could
anticip
inde
new
case
sar
identifi
earli
anim
reservoir
origin
sarscov
known
although
viru
isol
civet
cat
wild
anim
sarscov
genet
distinct
three
class
coronaviru
share
homolog
group
ii
group
iii
coronavirus
fig
recent
studi
suggest
mix
mammalian
avian
lineag
possibl
mean
recombin
epidem
spread
sar
strain
also
cocircul
guandong
rais
question
whether
one
strain
sarscov
transmiss
anoth
sar
appear
spread
droplet
fomit
mean
contact
mucou
membran
directli
indirectli
instanc
super
spreader
case
caus
disproportion
number
success
transmissionshav
note
sarscov
isol
multipl
specimen
type
includ
blood
suggest
system
spread
bodi
clinic
featur
sar
includ
incub
period
day
mean
day
initi
symptom
includ
fever
c
malais
myalgia
chill
rigor
respiratori
symptom
sometim
wateri
diarrhea
occur
later
cours
ill
sar
less
commonli
associ
upper
respiratori
symptom
like
rhinorrhea
sore
throat
regard
sever
one
third
patient
improv
spontan
wherea
patient
requir
intens
care
need
mechan
ventil
autopsi
specimen
diffus
alveolar
damag
seen
variou
level
progress
sever
fig
age
older
coexist
ill
predict
wors
cours
death
attribut
respiratori
failur
multipl
organ
failur
comorbid
exist
medic
condit
studi
suggest
interferon
corticosteroid
may
improv
clinic
cours
sar
data
random
placebocontrol
trial
still
need
demonstr
efficaci
addit
possibl
longterm
sequela
therapi
unclear
investig
current
studi
efficaci
antivir
drug
well
identif
sarscov
clinic
diagnosi
sar
base
larg
exposur
histori
case
definit
suspect
probabl
case
rtpcr
methodolog
rapidli
develop
assist
laboratori
diagnosi
sar
cell
cultur
sarscov
demonstr
cpe
vero
cell
line
foci
cell
round
cell
refract
occasion
syncytia
fig
howev
realtim
rtpcr
assay
current
repres
mainstay
laboratori
diagnosi
nasopharyng
aspir
swab
typic
specimen
test
dna
microarray
techniqu
may
also
appear
near
futur
convalesc
sera
use
establish
sar
infect
retrospect
use
whole
viru
immunoassay
biosafeti
protocol
handl
materi
contain
sarscov
exist
adher
strictli
laboratoryacquir
infect
sarscov
occur
singapor
taipei
latter
case
laboratori
west
nile
viru
wnv
first
isol
uganda
first
emerg
unit
state
sinc
time
number
case
wnv
unit
state
continu
climb
american
strain
wnv
appear
origin
middl
east
although
specif
mechan
introduct
unit
state
remain
undetermin
wnv
member
famili
flavivirida
genu
flaviviru
serolog
wnv
member
japanes
enceph
viru
antigen
complex
wnv
maintain
cycl
transmiss
mosquito
bird
back
mosquito
although
culex
speci
mosquito
appear
primari
vector
wnv
found
speci
tick
eastern
hemispher
north
american
bird
speci
serv
host
wnv
bird
migrat
appear
play
role
mainten
propag
viru
natur
natur
mammalian
infect
wnv
document
hors
human
consid
deadend
host
howev
case
report
transmiss
utero
via
breastfeed
accident
percutan
laboratori
exposur
organ
transplant
blood
transfus
report
last
two
rout
led
revis
blood
donor
deferr
criteria
nucleic
acid
test
donat
blood
human
case
infect
wnv
lead
clinic
diseas
typic
incub
period
day
uncompl
case
begin
sudden
onset
fever
c
headach
myalgia
often
gastrointestin
symptom
maculopapular
rash
lymphadenopathi
may
also
occur
half
patient
case
usual
last
less
week
although
linger
fatigu
common
almost
patient
infect
wnv
develop
sever
ill
rang
uncompl
viral
mening
debilit
flaccid
paralysi
age
year
import
risk
factor
central
nervou
system
cn
complic
includ
tremor
myoclonu
seizur
patient
wnvassoci
flaccid
paralysi
rel
young
asymmetr
weak
sensori
involv
cn
involv
carri
mortal
wnv
enceph
appear
particularli
lethal
longterm
morbid
almost
two
third
patient
wnv
enceph
linger
neurolog
difficulti
year
acut
ill
initi
replic
wnv
thought
occur
skin
region
lymph
node
seed
reticuloendotheli
system
result
secondari
viremia
may
seed
cn
adhes
neuroinvas
mediat
e
protein
patholog
cn
find
includ
diffus
inflamm
brainstem
microgli
nodul
area
perivascular
inflamm
proxim
brainstem
anim
infect
wnv
anterior
horn
cell
show
degener
neuron
cell
death
wnv
antigen
local
mainli
within
gray
matter
spinal
cord
find
provid
patholog
explan
wnvassoci
flaccid
paralysi
similar
find
recent
report
fatal
human
case
wnv
affin
wnv
tissu
remain
unexplain
serolog
acut
convalesc
sera
remain
primari
mean
laboratori
confirm
wnv
infect
panel
flavivirus
also
includ
comparison
presumpt
diagnosi
made
enzym
immunoassay
immunofluoresc
antibodi
assay
antiwnv
igm
although
igm
persist
patient
sever
month
acut
infect
isol
wnv
clinic
specimen
prove
difficult
molecular
assay
exist
low
magnitud
transient
viremia
human
limit
clinic
valu
number
antivir
treatment
wnv
show
promis
vitro
includ
nucleosid
analogu
eg
ribavirin
interferona
human
immunoglobulin
clinic
data
support
use
patient
moment
support
manag
ventilatori
support
treatment
cerebr
edema
key
measur
benefit
prophylact
steroid
osmot
agent
remain
unknown
human
vaccin
wnv
current
avail
research
today
emerg
viral
infect
supersed
yet
viral
infect
futur
see
hint
futur
viral
infect
emerg
infect
cover
articl
encroach
previous
unvisit
habitat
eg
hantavirus
air
travel
eg
sar
accident
import
eg
monkeypox
exampl
sar
demonstr
quickli
emerg
viral
infect
spread
also
quickli
identifi
contain
motiv
cooper
likewis
research
vaccin
antivir
treatment
virus
must
continu
